Fig. 14
From: Shared neoantigens’ atlas for off-the-shelf cancer vaccine development
Coverage of off-the-shelf cancer vaccines based on targetable shared NeoAgs. The geographic applicability of off-the-shelf cancer vaccines based on targetable shared NeoAgs is shown according the HLA haplotypes frequency in distinct world populations. The size of the connecting ribbons correlates with the percentage of the specific SNV or InDel mutation in each tumor type (left). The height of the bar indicates the total percentage of cancer types targetable in each Continent, based on the HLA haplotype prevalence (right)